Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07202520

Evaluation of the Benefit of the H'Ability Home Device Used in Supervised Self-rehabilitation at Home on the Autonomy of Post-stroke Patients

The goal of this clinical investigation is to evaluate the benefit of the H'Ability Home device used in supervised self-rehabilitation at home on the autonomy of post-stroke patients.

Participants will perform their self-rehabilitation exercises at home using a virtual reality headset incorporating H'Ability Home software for 6 weeks during the experimental phase. This phase will be compared to a 6-week control phase at home, with self-rehabilitation exercises presented in a paper format.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fondation Hopale - Centre de Jacques Calvé, Berck, France

Loading trial locations.

About this study

This is a prospective, multicenter, randomized, controlled, crossover, and repeated-measures clinical study.

Patients with a first stroke, currently undergoing rehabilitation in a center with a planned return home, and with low to reasonable susceptibility to motion sickness will be enrolled.

After inclusion, patients will be randomized to one of two study arms.

  • Arm 1: Experimental phase / Washout / Control phase
  • Arm 2: Control phase / Washout phase / Experimental phase

During the experimental phase, patients will perform their self-rehabilitation exercises at home using the H'Ability Home device for six weeks.

During the control phase, patients will perform their self-rehabilitation exercises at home using a paper-based exercise guide for six weeks. The two study phases are separated by a one-week washout period during which patients will not perform any self-rehabilitation exercises.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patient Inclusion Criteria:

  • Stroke diagnosis: first stroke, with no history of stroke, documented in the medical record
  • Currently in rehabilitation (in a center) (full hospitalization or day hospitalization for at least 3 days/week) for another 2 to 4 weeks.
  • Planned return home (home self-rehabilitation phase): Patients at the end of their rehabilitation stay and scheduled to return home where the self-rehabilitation phase can take place.
  • Ability to use virtual reality: Physical and cognitive ability to interact with virtual reality devices, at the discretion of therapists.
  • Adult: Patients aged 18 years or older.
  • Informed consent: Voluntary agreement to participate in the study after a full explanation of its terms and conditions.
  • Member of a social security scheme or eligible beneficiary
  • Distance between home and center included within the usual perimeter of each site.
  • Presence of a third-party family caregiver at home who has agreed to ensure the patient's safety during self-rehabilitation sessions with the H'Ability Home device (consent)
  • Availability of a Wi-Fi network and internet access at the patient's home
  • Presence of an adequate space at home to perform rehabilitation exercises
  • Person with low to reasonable sensitivity to motion sickness (MSSQ ≤ 15)

Patient non inclusion Criteria:

  • • Visual disorders incompatible with the use of virtual reality (absence of binocular vision, blindness, conjunctivitis, etc.) at the discretion of the investigator. PS: Visual disorders corrected by wearing a vision correction device are not concerned because glasses or contact lenses can be worn when using an IVR headset.
  • Major cognitive impairment: Severe cognitive impairment affecting the patient's ability to understand or follow study instructions, or to operate the device independently, at the investigators' discretion.
  • History of epilepsy: History of epileptic seizures, particularly photosensitive seizures, which may be triggered or aggravated by the use of virtual reality.
  • Medical instability: presence of unstable or uncontrolled medical conditions that could interfere with active participation in rehabilitation.
  • Psychiatric illnesses: active psychiatric disorders (e.g., psychosis, unstabilized bipolar disorder) that could disrupt participation and continuity of rehabilitation, at the investigators' discretion.
  • Wearing implantable medical devices or personal medical devices that could be affected by radio waves (pacemakers, cochlear implants, etc.)
  • Participation in another clinical study: engagement in another clinical study likely to interfere with the study objectives or outcome assessments
  • Planned hospitalization during the home self-rehabilitation period
  • Pregnant, childbirth, or breastfeeding women
  • Persons deprived of their liberty by a judicial (including guardianship, curatorship, and judicial protection) or administrative decision
  • Persons receiving psychiatric care or admitted to a health or social care facility for purposes other than research
  • Persons in an emergency situation unable to express their prior consent

Third-party family caregiver Inclusion Criteria:

  • Adult: Person aged 18 years or older
  • Informed consent: Voluntary agreement to participate in the study after a full explanation of its terms and conditions.
  • Member of a social security scheme or entitled person
  • Patient's family caregiver
  • Ability to assist the patient in using the device
  • Ability to ensure the patient's safety when using the device
  • Agreement to assist and ensure the patient's safety when using the device at home
  • Agreement to provide feedback on the device by completing self-administered questionnaires (UTAUT) - optional

Third-party family caregiver non-inclusion Criteria:

  • Pregnant, childbirth, or breastfeeding women
  • Persons deprived of their liberty by a judicial (including guardianship, curatorship, and judicial protection) or administrative decision
  • Persons receiving psychiatric care or admitted to a health or social care facility for purposes other than research
  • Persons in an emergency situation unable to express their prior consent

Treatment and study plan

IVR : H'Ability Home

Device

H'Ability Home is a Dtx (Digital therapeutics) designed for the neurological rehabilitation of patients who have suffered a stroke, via a wireless virtual reality headset, with a simplified control interface on a tablet or PC

Control: paper-based exercise guide

Device

self-rehabilitation booklet used in current practice in centers

Other names: Control

Primary outcomes

  1. To evaluate the impact of the H'Ability Home device on the level of autonomy of post-stroke patients compared to the exercise booklet.

    Time frame: T0 (screening), T1(Baseline), T2(week 6), T3(week 7), T4 (week 13)

    Level of autonomy by the functional independence measure (FIM) score. From 18 (no autonomy) to 126 (full autonomy).

Secondary outcomes

  1. To evaluate the impact of the H'Ability Home device on the walking speed of post-stroke patients compared to the exercise booklet.

    Time frame: T0 (screening), T1(Baseline), T2(week 6), T3(week 7), T4 (week 13)

    walking speed by the duration of the 10 meters of walking

  2. To evaluate the impact of the H'Ability Home device on the coordination of post-stroke patients compared to the exercise booklet.

    Time frame: T0 (screening), T1(Baseline), T2(week 6), T3(week 7), T4 (week 13)

    coordination by the Quick-DASH score (DASH: Disabilities of the Arm, Shoulder and Hand). scored from 11 (no incapacity) to 100 (full incapacity)

  3. To evaluate the impact of the H'Ability Home device on the quality of life of post-stroke patients compared to the exercise booklet.

    Time frame: T1(Baseline), T2(week 6), T3(week 7), T4 (week 13)

    quality of life by the EuroQoL-5D score. from 1 (no problem) to 5 (extreme problems)

  4. Evaluate the impact of the H'Ability Home device on satisfaction with rehabilitation exercises in post-stroke patients compared to the exercise booklet.

    Time frame: T2(week 6), T4 (week 13)

    satisfaction by the visual digital scale Satisfaction score. From 0 (total insatisfaction) to 10 (total satisfaction)

  5. To evaluate the effect of the H'Ability Home device on the cognitive abilities of post-stroke patients compared to the exercise booklet.

    Time frame: T1(Baseline), T2(week 6), T3(week 7), T4 (week 13)

    cognitive abilities by Mini-Mental State Examination score. From 0 (significant cognitive impairment) to 30 (optimal cognitive abilities)

  6. Evaluate the impact of the H'Ability Home device on the fear of falling in relation to the exercise booklet.

    Time frame: T1(Baseline), T2(week 6), T3(week 7), T4 (week 13)

    fear of falling by the Short-Falls Efficacy Scale-International score scored from 7 (minimal fear) to 28 (maximal fear)

  7. Describe patient compliance with both devices: H'Ability Home and exercise booklet.

    Time frame: T2(week 6), T4 (week 13)

    compliance by number of connections or achievements

  8. Evaluate the acceptability of the H'Ability Home device among patients and caregivers before use (a priori acceptability) and after use (a posteriori acceptability)

    Time frame: T0 (screening), T2(week 6), T4 (week 13)

    acceptability by the score of the Unified Theory of Acceptance and the Use of Technology dimensions. caregiver: from 28 (low acceptance) to 196 (high acceptance). patients: from 31 (low acceptance) to 217 (high acceptance)

  9. Describe the level of mental load of patients with the two devices: H'Ability Home and exercise booklet

    Time frame: T2(week 6), T4 (week 13)

    mental load by NASA Task Load Index score. from 0 (low cognitive load) to 100 (high cognitive load)

  10. Describe the level of motion sickness associated with the use of the H'Ability Home virtual reality device

    Time frame: T2(week 6), T4 (week 13)

    motion sickness by Simulator Sickness Questionnaire score. From 0 (no cinetose) to 48 (severe cinetose)

Study contacts

Contact information is provided by the study sponsor or research team.

Emilie LEBLONG, MD, PhD

CONTACT

[email protected]

0033 2 99 29 50 99

Sponsors and collaborators

Lead sponsor

H'ability

Industry

Collaborators

  • Pôle Saint Hélier

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Oct 1, 2025
Registry last updated
Oct 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.